It might be commonplace, but the Epstein-Barr virus (EBV) can be deadly, causing several types of cancer, including nasopharyngeal carcinoma, one of Hong Kong’s most lethal. CUHK researchers have developed a groundbreaking mRNA-based drug that effectively makes cancer cells infected with EBV self-destruct. By selectively eliminating virally infected cancer cells, this innovative therapy could offer a more effective and gentler way to treat this challenging form of cancer.

Professor Katalin Karikó’s story is a shining example of how the power of persistence can lead to discoveries that change the world. In the face of countless obstacles, she tenaciously pursued her vision of utilising mRNA for therapy for decades. Alongside Professor Drew Weissman, their research paved the way for the development of life-saving Covid vaccines. She embodies not only relentless pursuit of scientific knowledge, but also the hope to ignite passion and inspire young minds about the wonders of science.